Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation.

Mena A, Smith EE, Burns JL, Speert DP, Moskowitz SM, Perez JL, Oliver A.

J Bacteriol. 2008 Dec;190(24):7910-7. doi: 10.1128/JB.01147-08. Epub 2008 Oct 10.

2.

Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance.

Oliver A, Mena A.

Clin Microbiol Infect. 2010 Jul;16(7):798-808. doi: 10.1111/j.1469-0691.2010.03250.x. Review.

3.

Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients.

Marvig RL, Sommer LM, Jelsbak L, Molin S, Johansen HK.

Future Microbiol. 2015;10(4):599-611. doi: 10.2217/fmb.15.3. Review.

PMID:
25865196
4.

The problems of antibiotic resistance in cystic fibrosis and solutions.

López-Causapé C, Rojo-Molinero E, Macià MD, Oliver A.

Expert Rev Respir Med. 2015 Feb;9(1):73-88. doi: 10.1586/17476348.2015.995640. Epub 2014 Dec 26. Review.

PMID:
25541089
5.

Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.

Hogardt M, Heesemann J.

Curr Top Microbiol Immunol. 2013;358:91-118. doi: 10.1007/82_2011_199. Review.

PMID:
22311171
6.

Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy.

Oliver A.

Int J Med Microbiol. 2010 Dec;300(8):563-72. doi: 10.1016/j.ijmm.2010.08.009. Epub 2010 Sep 15. Review.

PMID:
20837399
7.

Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung.

Hogardt M, Heesemann J.

Int J Med Microbiol. 2010 Dec;300(8):557-62. doi: 10.1016/j.ijmm.2010.08.008. Epub 2010 Oct 12. Review.

PMID:
20943439
8.

Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections.

Winstanley C, O'Brien S, Brockhurst MA.

Trends Microbiol. 2016 May;24(5):327-337. doi: 10.1016/j.tim.2016.01.008. Epub 2016 Mar 3. Review.

9.
10.

Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis.

Cramer N, Wiehlmann L, Tümmler B.

Int J Med Microbiol. 2010 Dec;300(8):526-33. doi: 10.1016/j.ijmm.2010.08.004. Epub 2010 Oct 14. Review.

PMID:
20951087
11.

Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

Folkesson A, Jelsbak L, Yang L, Johansen HK, Ciofu O, Høiby N, Molin S.

Nat Rev Microbiol. 2012 Dec;10(12):841-51. doi: 10.1038/nrmicro2907. Epub 2012 Nov 13. Review.

PMID:
23147702
12.

Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status.

Hraiech S, Brégeon F, Rolain JM.

Drug Des Devel Ther. 2015 Jul 16;9:3653-63. doi: 10.2147/DDDT.S53123. eCollection 2015. Review.

13.

Advances in understanding Pseudomonas.

Tümmler B, Wiehlmann L, Klockgether J, Cramer N.

F1000Prime Rep. 2014 Feb 3;6:9. doi: 10.12703/P6-9. eCollection 2014. Review.

14.

Transient and heritable mutators in adaptive evolution in the lab and in nature.

Rosenberg SM, Thulin C, Harris RS.

Genetics. 1998 Apr;148(4):1559-66. Review.

15.

Hypermutation and stress adaptation in bacteria.

Jayaraman R.

J Genet. 2011 Aug;90(2):383-91. Review.

16.

Too many mutants with multiple mutations.

Drake JW.

Crit Rev Biochem Mol Biol. 2007 Jul-Aug;42(4):247-58. Review.

Supplemental Content

Support Center